Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential Value of Axial Length and Central Corneal Thickness in the Assessment for Risk of Permanent Optic Nerve Damage and Visual Field Loss in Benign Intracranial Hypertension

NCT02541994 is registered in ClinicalTrials.gov with Ochsner Health System as lead sponsor.

NCT NCT02541994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential Value of Axial Length and Central Corneal Thickness in the Assessment for Risk of Permanent Optic Nerve Damage and Visual Field Loss in Benign Intracranial Hypertension
Lead sponsor
Ochsner Health System
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2015
Completion date
September 30, 2017
Enrollment
5 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign intracranial hypertension